It is likely that an effective therapy would involve delivery of agents (viral vectors expressing neurotrophins, antibodies, protein anti-aggregation drugs, anti-inflammatory agents) that are aimed at halting or slowing the typical long-term PD progression towards frank dementia. Here, BDNF is linked to dementia.